Surgical Treatment of Age-Related Macular Degeneration

REFERENCES

• Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. Jan 1997;104(1):7–21.
   PubMedGoogle Scholar
• Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration.Surv Ophthalmol. May-Jun 1988;32(6):375–413.
   PubMedGoogle Scholar
• Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol. Sep 1991;109(9):1220–1231.
   PubMedGoogle Scholar
• de Juan E, Jr., Machemer R. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol. Jan 15 1988;105(1):25–29.
   PubMedGoogle Scholar
• Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, Lowe MA. Surgical management of subfoveal choroidal neovascularization. Ophthalmology. Jun 1992;99(6):952–968; discussion 975-956.
   PubMedGoogle Scholar
• Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results. Ophthalmology. Jun 1992;99(6):969–975; discussion 975-966.
   PubMedGoogle Scholar
• Sabates FN, Fletcher DC. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. Aug 15 1992;114(2):241–242.
   PubMedGoogle Scholar
• Lambert HM, Capone A, Jr., Aaberg TM, Sternberg P, Jr., Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. Mar 15 1992;113(3):257–262.
   PubMedGoogle Scholar
• Krasnov MM, Stolyarenko GE. Surgical management of exudative maculopathies: Preliminary report. Eur J Ophthalmol. Jul-Sep 1992;2(3):122–128.
   PubMedGoogle Scholar
• Falkner C, Leitich H, Frommlet F, Bauer P, Binder S. The end of submacular surgery for age-related macular degeneration? A meta-analysis. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2007;245(4):490–501.
   PubMedGoogle Scholar
• Lewis H, VanderBrug Medendorp S. Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: A randomized, double-masked trial. Ophthalmology. Nov 1997;104(11):1847–1851; discussion 1852.
   PubMedGoogle Scholar
• Bressler NM, Bressler SB, Hawkins BS, Marsh MJ, Sternberg P, Jr., Thomas MA. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes submacular surgery trials pilot study report number 1. Am J Ophthalmol. Oct 2000;130(4):387–407.
   PubMedGoogle Scholar
• Hawkins BS, Bressler NM, Miskala PH, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Ophthalmic findings: SST report no. 11. Ophthalmology. Nov 2004;111(11):1967–1980.
   PubMedGoogle Scholar
• Bressler NM, Bressler SB, Childs AL, et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic findings: SST report no. 13. Ophthalmology. Nov 2004;111(11):1993–2006.
   PubMedGoogle Scholar
• Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol. Nov 1993;231(11):635–641.
   PubMedGoogle Scholar
• Ninomiya Y, Lewis JM, Hasegawa T, Tano Y. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes. Am J Ophthalmol. Nov 1996;122(5):613–621.
   PubMedGoogle Scholar
• de Juan E, Jr., Loewenstein A, Bressler NM, Alexander J. Translocation of the retina for management of subfoveal choroidal neovascularization II: A preliminary report in humans. Am J Ophthalmol. May 1998;125(5):635–646.
   PubMedGoogle Scholar
• Pieramici DJ, De Juan E, Jr., Fujii GY, et al. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. Oct 2000;130(4):419–428.
   PubMedGoogle Scholar
• Toth CA, Freedman SF. Macular translocation with 360-degree peripheral retinectomy impact of technique and surgical experience on visual outcomes. Retina. 2001;21(4):293–303.
   PubMedGoogle Scholar
• Abdel-Meguid A, Lappas A, Hartmann K, et al. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol. May 2003;87(5):615–621.
   PubMedGoogle Scholar
• Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol. Oct 2002;134(4):560–565.
   PubMedGoogle Scholar
• Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. Apr 1999;237(4):313–325.
   PubMedGoogle Scholar
• Aisenbrey S, Lafaut BA, Szurman P, et al. Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol. Apr 2002;120(4):451–459.
   PubMedGoogle Scholar
• Mruthyunjaya P, Stinnett SS, Toth CA. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Ophthalmology. Sep 2004;111(9):1715–1724.
   PubMedGoogle Scholar
• Toth CA, Lapolice DJ, Banks AD, Stinnett SS. Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy. Graefes Arch Clin Exp Ophthalmol. Jul 2004;242(7):541–548.
   PubMedGoogle Scholar
• Gelisken F, Voelker M, Schwabe R, et al. Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol. Aug 2007;245(8):1085–1095.
   PubMedGoogle Scholar
• Luke M, Ziemssen F, Volker M, et al. Full macular translocation (FMT) versus photodynamic therapy (PDT) with verteporfin in the treatment of neovascular age-related macular degeneration: 2-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol. Jun 2009;247(6):745–754.
   PubMedGoogle Scholar
• Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC, Jr., Desai U. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. Feb 1991;22(2):102–108.
   PubMedGoogle Scholar
• Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. Dec 1994;232(12):707–716.
   PubMedGoogle Scholar
• Algvere PV, Berglin L, Gouras P, Sheng Y, Kopp ED. Transplantation of RPE in age-related macular degeneration: Observations in disciform lesions and dry RPE atrophy. Graefes Arch Clin Exp Ophthalmol. Mar 1997;235(3):149–158.
   PubMedGoogle Scholar
• Thumann G, Aisenbrey S, Schraermeyer U, et al. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol. Oct 2000;118(10):1350–1355.
   Google Scholar
• Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: A pilot study. Am J Ophthalmol. Feb 2002;133(2):215–225.
   PubMedGoogle Scholar
• Falkner-Radler CI, Krebs I, Glittenberg C, et al. Human retinal pigment epithelium (RPE) transplantation: Outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study. Br J Ophthalmol. Mar 2011;95(3):370–5.
   PubMedGoogle Scholar
• MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. Dec 2005;112(12):2081–2087.
   PubMedGoogle Scholar
• Fine HF, Iranmanesh R, Del Priore LV, et al. Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration. Retina. Nov-Dec;30(10):1588–1594.
   PubMedGoogle Scholar
• Kuhli-Hattenbach C, Fischer IB, Schalnus R, Hattenbach LO. Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy. Am J Ophthalmol. Feb;149(2):316–321 e311.
   PubMedGoogle Scholar
• Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213(2):97–102.
   PubMedGoogle Scholar
• Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. Oct 1999;106(10):1900–1906; discussion 1906–1907.
   PubMedGoogle Scholar
• Peyman GA, Nelson NC, Jr., Alturki W, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg. Oct 1991;22(10):575–582.
   PubMedGoogle Scholar
• Ron Y, Ehrlich R, Axer-Siegel R, Rosenblatt I, Weinberger D. Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration. Ophthalmologica. 2007;221(1):57–61.
   PubMedGoogle Scholar
• Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A, N S. Pneumatic displacement of submacular hemorrhage: Safety, efficacy, and patient selection. Retina. Mar 2007;27(3):329–334.
   PubMedGoogle Scholar
• Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol. Apr 1999;237(4):273–277.
   PubMedGoogle Scholar
• Hattenbach LO, Klais C, Koch FH, Gumbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. Aug 2001;108(8):1485–1492.
   PubMedGoogle Scholar
• Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina. Mar 2007;27(3):321–328.
   PubMedGoogle Scholar
• Tsai SC, Lin JM, Chen HY. Intravitreous recombinant tissue plasminogen activator and gas to treat submacular hemorrhage in age-related macular degeneration. Kaohsiung J Med Sci. Dec 2003;19(12):608–616.
   PubMedGoogle Scholar
• Haupert CL, McCuen BW, 2nd Jaffe, GJ, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. Feb 2001;131(2):208–215.
   PubMedGoogle Scholar
• Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology. Jun 2004;111(6):1201–1208.
   PubMedGoogle Scholar
• Singh RP, Patel C, Sears JE. Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator. Br J Ophthalmol. Apr 2006;90(4):429–431.
   PubMedGoogle Scholar
• Vander JF, Federman JL, Greven C, Slusher MM, Gabel VP. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology. Jan 1991;98(1):23–27.
   PubMedGoogle Scholar
• Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol. Jan 1995;113(1):62–69.
   PubMedGoogle Scholar
• Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol. Dec 1999;128(6):739–746.
   PubMedGoogle Scholar
• Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. Jan 2010;248(1):5–11.
   PubMedGoogle Scholar
• Kamei M, Tano Y. Tissue plasminogen activator-assisted vitrectomy: surgical drainage of submacular hemorrhage. Dev Ophthalmol. 2009;44:82–88.
   PubMedGoogle Scholar
• Shah SP, Hubschman JP, Gonzales CR, Schwartz SD. Submacular combination treatment for management of acute, massive submacular hemorrhage in age-related macular degeneration. Ophthalmic Surg Lasers Imaging. May-Jun 2009;40(3):308–315.
   PubMedGoogle Scholar
• Guthoff R, Guthoff T, Meigen T, Goebel W. Intravitreous Injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration. Retina. Jan 2011;31(1):36–40.
   PubMedGoogle Scholar
• Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. Jan 1995;36(1):182–191.
   PubMedGoogle Scholar
• Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol. Jul-Sep 1999;9(3):217–230.
   PubMedGoogle Scholar
• Joussen AM, Joeres S, Fawzy N, et al. Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology. Mar 2007;114(3):551–560.
   PubMedGoogle Scholar
• Eckardt C, Eckardt U. Macular translocation in nonexudative age-related macular degeneration. Retina. Dec 2002;22(6):786–794.
   PubMedGoogle Scholar
• Cahill MT, Mruthyunjaya P, Bowes Rickman C, Toth CA. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol. Jul 2005;123(7):935–938.
   PubMedGoogle Scholar
• Khurana RN, Fujii GY, Walsh AC, Humayun MS, de Juan E, Jr., Sadda SR. Rapid recurrence of geographic atrophy after full macular translocation for nonexudative age-related macular degeneration. Ophthalmology. Sep 2005;112(9):1586–1591.
   PubMedGoogle Scholar
• Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology. Jan 2009;116(1):57–65 e55.
   PubMedGoogle Scholar
• Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. Oct 5 2006;355(14):1419–1431.
   PubMed Web of Science ®Google Scholar
• Lux A, Llacer H, Heussen FM, Joussen AM. Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol. Oct 2007;91(10):1318–1322.
   PubMedGoogle Scholar
• Haverbeke GM, Claes C. Full macular translocation for choroidal neovascularization in the era of intravitreal pharmacological therapy. Retina. Nov-Dec 2010;30(10):1739–1743.
   PubMedGoogle Scholar
• Heriot WJ. Intravitreal gas and TPA: An outpatient procedure for submacular hemorrhage. Paper presented at AAO Annual Vitreoretinal Update, 1996, Chicago, Illinois.
   Google Scholar